Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These abnormal, swollen neurites were invariably near plaques and appeared analogous to those observed in other AD mouse models [8, 23, 56, 67, 76, 89, 119] as well as human AD brains [45, 66, 72, 92, 100].”
From The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques (2013) · cites this paper as [56]
In the citing paper
“Dystrophic neurites have been shown to be positive for markers of autophagy [14, 45, 72] and are typically filled with an abundance of autophagic intermediates, as viewed at the EM level [8, 23, 45, 56, 67, 72, 76, 89, 100, 119].”
From The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques (2013) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.
Busciglio, J., Gabuzda, D. H., Matsudaira, P., & Yankner, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2092 · Cited by 569
Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., & Heyman, A. (1996) · Neurology · doi:10.1212/wnl.46.6.1592 · Cited by 561
Research works printed but not linked: 35
- Cook, 1997, Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nat. Med., 3, 1021, 10.1038/nm0997-1021 · DOI · Paper page
- Dickson, 1997, The pathogenesis of senile plaques, J. Neuropathol. Exp. Neurol., 56, 321, 10.1097/00005072-199704000-00001 · DOI · Paper page
- Duff, 1996, Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1, Nature, 383, 710, 10.1038/383710a0 · DOI · Paper page
- Frautschy, 1998, Microglial response to amyloid plaques in APPsw transgenic mice, Am. J. Pathol., 152, 307
- Funato, 1998, Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain, Am. J. Pathol., 152, 983
- Gallyas, 1992, Formation of “dark” (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis), Acta Neuropathol., 83, 504, 10.1007/BF00310027 · DOI
- Haass, 1997, Presenilins: Genes for life and death, Neuron, 18, 687, 10.1016/S0896-6273(00)80309-8 · DOI
- Hardy, 1997, The Alzheimer family of diseases, many aetiologies, one pathogenesis?, Proc. Natl. Acad. Sci. USA, 94, 2025, 10.1073/pnas.94.6.2095 · DOI · Paper page
- Hardy, 1992, Alzheimer's disease: The amyloid cascade hypothesis, Science, 256, 184, 10.1126/science.1566067 · DOI · Paper page
- Hartmann, 1997, Distinct sites of intracellular production of Alzheimer's disease Aβ 40/42 amyloid peptides, Nat. Med., 3, 1016, 10.1038/nm0997-1016 · DOI · Paper page
- Holcomb, 1998, Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 genes, Nat. Med., 4, 97, 10.1038/nm0198-097 · DOI · Paper page
- Hsiao, 1996, Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
- Ida, 1996, Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid by a newly developed sensitive Western blot assay, J. Biol. Chem., 271, 22908, 10.1074/jbc.271.37.22908 · DOI · Paper page
- Iwatsubo, 1995, Amyloid β-protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome, Ann. Neurol., 37, 294, 10.1002/ana.410370305 · DOI · Paper page
- Johnson-Wood, 1997, Amyloid precursor processing and Aβ42 deposition in a transgenic mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 94, 1550, 10.1073/pnas.94.4.1550 · DOI
- Kurt, 1999, β-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain: An electron microscope study, Exp. Neurol., 158, 221, 10.1006/exnr.1999.7096 · DOI
- LeBlanc, 1997, Processing of Amyloid precursor protein in human primary neurons and astrocyte cultures, J. Neurochem., 68, 1183, 10.1046/j.1471-4159.1997.68031183.x · DOI · Paper page
- Mandybur, 1975, The incidence of cerebral amyloid angiopathy in Alzheimer's disease, Neurology, 25, 120, 10.1212/WNL.25.2.120 · DOI · Paper page
- Mann, 1996, Diffuse plaques in cerebellum and corpus striatum in Down's syndrome contain amyloid β protein (Aβ) only in the form of Aβ42(43), Neurodegeneration, 5, 115, 10.1006/neur.1996.0017 · DOI
- Masliah, 1996, Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease, J. Neurosci., 16, 5795, 10.1523/JNEUROSCI.16-18-05795.1996 · DOI · Paper page
- McGowan, 1999, Amyloid phenotype characterisation of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes, Neurobiol. Dis., 6, 231, 10.1006/nbdi.1999.0243 · DOI · Paper page
- Mestre-Frances, 2000, Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcerebrus murinus reveal distinct amyloid β1–42 and β1–40 immunoreactivity profiles, Neurobiol. Dis., 7, 1, 10.1006/nbdi.1999.0270 · DOI · Paper page
- Nishimura, 1998, Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer, J. Neurosci., 18, 2387, 10.1523/JNEUROSCI.18-07-02387.1998 · DOI
- Oyama, 1998, Age-dependent increase of amyloid β-protein (Aβ) 42 in the brain of mutant presenilin 2 transgenic mouse, Neurobiol. Aging, Suppl. 4S, 1175
- Pike, 1995, Early association of reactive astrocytes with senile plaques in Alzheimer's disease, Exp. Neurol., 132, 172, 10.1016/0014-4886(95)90022-5 · DOI · Paper page
- Sclossmacher, 1992, Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes, Neurobiol. Aging, 13, 421, 10.1016/0197-4580(92)90117-G · DOI
- Shoji, 1990, The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels, Brain Res., 530, 113, 10.1016/0006-8993(90)90665-X · DOI
- Tokuda, 1996, Amyloid beta protein and its 3-kDa fragment are present in the axoplasm fraction of the white matter in human brain, Biochem. Biophys. Res. Commun., 223, 165, 10.1006/bbrc.1996.0863 · doi:10.1006/bbrc.1996.0863
- Venable, 1965, A simplified lead citrate stain for use in electron microscopy, J. Cell Biol., 25, 407, 10.1083/jcb.25.2.407 · DOI · Paper page
- Watson, 1958, Staining of tissue sections for electron microscopy with heavy metals, J. Biophys. Biochem. Cytol., 4, 475, 10.1083/jcb.4.4.475 · DOI · Paper page
- Wengenack, 2000, Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain, Neuroscience, 101, 939, 10.1016/S0306-4522(00)00388-2 · DOI
- Wisniewski, 1989, Ultrastructural studies of the cells forming fibers in classical plaques, Can. J. Neurol. Sci., 16, 535, 10.1017/S0317167100029887 · DOI · Paper page
- Wisniewski, 1996, Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines, Neuropathol. Appl. Neurobiol., 22, 3, 10.1111/j.1365-2990.1996.tb00839.x · DOI · Paper page
- Yamada, 1997, Interrelationship between beta-amyloid deposition and complement-activated oligodendroglia, Dement. Geriatr. Cogn. Disord., 8, 267, 10.1159/000106643 · DOI
- Zhang, 1998, Destabilisation of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature, 395, 698, 10.1038/27208 · DOI · Paper page
Cited by
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
León, R., Garcia, A. G., & Marco‐Contelles, J. (2013) · Medicinal Research Reviews · doi:10.1002/med.20248 · Cited by 440
Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice
Trinchese, F., Liu, S., Battaglia, F., Walter, S., Mathews, P. M., & Arancio, O. (2004) · Annals of Neurology · doi:10.1002/ana.20101 · Cited by 373
Bartzokis, G., Sultzer, D., Lu, P. H., Nuechterlein, K. H., Mintz, J., & Cummings, J. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.005 · Cited by 363
Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease
Tan, M.-S., Tan, L., Jiang, T., Zhu, X.-C., Wang, H.-F., Jia, C.-D., & Yu, J.-T. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.348 · Cited by 347
Metadata
- Authors
- Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., Jennings, K. H., & Howlett, D. R.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 171
- Issue
- 1
- Pages
- 59-71
- ISSN
- 0014-4886
- Cited by
- 76
- References
- 16
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes. https://app.cochat.ai/papers/10.1006/exnr.2001.7717
- The paper
- Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., Jennings, K. H., & Howlett, D. R. (2001). Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes. Experimental Neurology. https://doi.org/10.1006/exnr.2001.7717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.